Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
There can be several reasons behind this: Decreased stomach acid production Digestion system not working properly or frequent vomiting/diarrhea In such a situation, doctors recommend giving MVI injection directly into the vein or muscle so that the body can get immediate nutrition
Results: A 40 year old male with no past medical problems presented with right thalamic and left frontal ICH
Option 3: Higher dose, shorter cycle Increase your dose to use the full vial within the stability window
Potential benefits Based on available literature, clinical trials, and anecdotal/clinical practice reports, these are the benefits most often cited: Fat loss / body composition improvement Reduction in overall body fat, especially subcutaneous & visceral fat
